| 前收市價 | 22.11 |
| 開市 | 22.18 |
| 買盤 | 22.00 x 100 |
| 賣出價 | 22.20 x 200 |
| 今日波幅 | 21.54 - 22.25 |
| 52 週波幅 | 11.25 - 58.38 |
| 成交量 | |
| 平均成交量 | 1,337,952 |
| 市值 | 1.527B |
| Beta 值 (5 年，每月) | -0.38 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.89 |
| 業績公佈日 | 2024年5月13日 - 2024年5月17日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 48.38 |
Insider MonkeyBillionaire Steve Cohen and Insiders Are Buying These 10 Stocks
In this article, we will take a detailed look at the Billionaire Steve Cohen and Insiders Are Buying These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Steve Cohen and Insiders Are Buying These 5 Stocks. Investors are holding their breath ahead of the key Fed decision about interest rates. While analysts expect the […]
ZacksMadrigal (MDGL) Stock Up as FDA Approves First Drug for NASH
Madrigal Pharmaceuticals' (MDGL) Rezdiffra (resmetirom) is the first and only medicine approved by the FDA for the treatment of NASH.
ZacksIonis (IONS) Drug Meets Mid-Stage MASH Study Goals
Ionis (IONS) reports positive phase II study results, which show that treatment with ION224 has the potential to improve MASH and prevent its progression to more severe stages.
